结核性硬化综合体中细胞癌和牛皮的共存:一个共享的mTOR路径发病?
Sunil Jaiswal1, Shraddha Uprety1, Mukesh Kumar Ranjan2
1Department of Dermatology Chitwan Medical College Bharatpur Nepal.
Clinical case reports
|September 25, 2025
概括
结核性硬化综合体 (TSC) 患者很少发生细胞癌 (RCC) 或牛皮. 这项研究强调了一名患有两种疾病的TSC患者,这表明共享的mTOR通路链接.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 遗传学 遗传学是一种遗传学.
背景情况:
- 结核性硬化综合体 (TSC) 是一种罕见的遗传疾病,导致良性瘤.
- 细胞癌 (RCC) 和牛皮在TSC患者中不常见.
- mTOR信号通路与TSC病变发生有关.
研究的目的:
- 在患有结核性硬化综合症的患者中报告一种罕见的细胞癌和牛皮并存的罕见病例.
- 探索潜在的共享分子机制,特别是mTOR通路激活,这些共同发生的基础.
主要方法:
- 一个30岁的男性患有已知的TSC病例报告.
- 临床表现包括广泛的斑块性牛皮.
- 在患者评估期间诊断细胞癌.
主要成果:
- 这名被诊断为TSC的患者既有广泛的斑块性牛皮,也有细胞癌.
- 这一案例凸显了这些情况在TSC患者中罕见的同时发生.
- 这些发现表明共享mTOR信号通路激活的潜在作用.
结论:
- 在结核性硬化综合体中细胞癌和牛皮的同时存在可能与共享的mTOR通路激活有关.
- 这一案例强调了考虑TSC患者的各种表现的重要性.
- 对mTOR途径在TSC并发症中的作用进行进一步研究是有必要的.
更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
719
04:12Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA
Published on: December 19, 2019
15.3K
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
5.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.4K
Rous Sarcoma Virus (RSV) and Cancer
6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.2K
The Retinoblastoma Gene
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.7K
Interactions Between Signaling Pathways
7.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
